S. van Buul-Offers

发表

Preclinical and Clinical In Vitro In Vivo Correlation of an hGH Dextran Microsphere Formulation

W. Hennink, D. Crommelin, R. Verrijk, 2007, Pharmaceutical Research.

Cellular growth in organs of dwarf mice during treatment with growth hormone, thyroxine and plasma fractions containing somatomedin activity.

J. van den Brande, S. van Buul-Offers, S. V. van Buul-Offers, 1982, Acta endocrinologica.

The effects of pituitary, thyroid, pancreatic and sexual hormones on body length and weight and organ weights of Snell dwarf mice.

S. van Buul-Offers, 1984, Growth.

Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice.

J. van den Brande, C. Kuper, C. Hoogerbrugge, 1994, Endocrinology.

T and B cell development in pituitary deficient insulin-like growth factor-II transgenic dwarf mice.

B. Zegers, R. Kooijman, S. van Buul-Offers, 1997, The Journal of endocrinology.

Abnormal Thymic Microenvironment in Insulin-Like Growth Factor-II Transgenic Mice

W. Savino, M. Dardenne, V. Cotta-de-Almeida, 2005, Neuroimmunomodulation.

The effect of dexamethasone on body and organ growth of normal and IGF-II-transgenic mice.

Raoul Rooman, S. van Buul-Offers, R. Bloemen, 1999, The Journal of endocrinology.

Short-term glucocorticoid treatment of piglets causes changes in growth plate morphology and angiogenesis.

K. de Meer, R. Sakkers, S. van Buul-Offers, 2003, Osteoarthritis and cartilage.

Differential patterns of insulin‐like growth factor‐I and ‐II mRNA expression in medulloblastoma

P. Wesseling, J. van Doorn, R. Reddingius, 2004, Neuropathology and applied neurobiology.

Insulinlike growth factor—ii/mannose 6‐phosphate receptor is expressed on ccl4‐exposed rat fat‐storing cells and facilitates activation of latent transforming growth factor‐β in cocultures with sinusoidal endothelial cells

E. Wisse, V. Rogiers, T. Niki, 1995 .

Human teratocarcinoma cells express functional insulin-like growth factor I receptors.

C. Mummery, E. J. V. van Zoelen, S. D. de Laat, 1989, Experimental cell research.

Expression of type I insulin-like growth factor receptors on human peripheral blood mononuclear cells.

C. Heijnen, B. Zegers, A. Schuurmans, 1992, Endocrinology.

Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.

J. van Doorn, K. Hoekman, C. Hoogerbrugge, 2002, Clinical chemistry.

The role of the IGF axis in IGFBP-1 and IGF-I induced renal enlargement in Snell dwarf mice.

A. Flyvbjerg, J. V. van Neck, S. Drop, 2001, The Journal of endocrinology.

Overexpression of human insulin-like growth factor-II in transgenic mice causes increased growth of the thymus.

E. Bonte, J. Sussenbach, S. Oei, 1995, The Journal of endocrinology.

Short-term glucocorticoid treatment of prepubertal mice decreases growth and IGF-I expression in the growth plate.

R. Berger, J. Smink, M. Gresnigt, 2003, The Journal of endocrinology.

Expression of insulin-like growth factor II (IGF-II) and histological changes in the thymus and spleen of transgenic mice overexpressing IGF-II

P. Roholl, L. V. D. van der Ven, S. van Buul-Offers, 1997, Histochemistry and Cell Biology.

The presence of classical insulin-like growth factor (IGF) type-I and -II receptors on mouse osteoblasts: autocrine/paracrine growth effect of IGFs?

S. Duursma, C. Hoogerbrugge, S. van Buul-Offers, 1990, The Journal of endocrinology.

Expression of insulin-like growth factors (IGFs), their receptors and IGF binding protein-3 in normal, benign and malignant smooth muscle tissues.

M. Welters, P. Roholl, J. Sussenbach, 1997, British Journal of Cancer.

Growth advantage of human leiomyoma cells compared to normal smooth‐muscle cells due to enhanced sensitivity toward insulin‐like growth factor I

M. Welters, P. Roholl, J. Sussenbach, 1994, International journal of cancer.

Production of insulin-like growth factors, platelet-derived growth factor, and transforming growth factors and their role in the density-dependent growth regulation of a differentiated embryonal carcinoma cell line.

C. Mummery, E. J. V. van Zoelen, I. Koornneef, 1989, Endocrinology.

Differential regulation of IGF-binding proteins in rabbit costal chondrocytes by IGF-I and dexamethasone.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 2000, The Journal of endocrinology.

Dexamethasone differentially inhibits thyroxine- or growth hormone-induced body and organ growth of Snell dwarf mice.

Raoul Rooman, S. van Buul-Offers, R. Bloemen, 2003, Endocrinology.

A comparison of in vitro bioassays to determine cellular glucocorticoid sensitivity.

S. van Buul-Offers, A. V. Verrijn Stuart, B. I. Hendriks-Stegeman, 2004, European journal of endocrinology.

Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture.

S. Duursma, S. van Buul-Offers, M. Herrmann‐Erlee, 1988, Acta endocrinologica.

Growth hormone is mitogenic for fetal mouse osteoblasts but not for undifferentiated bone cells.

S. Duursma, S. van Buul-Offers, M. Herrmann‐Erlee, 1988, The Journal of endocrinology.

Plasma levels of insulin‐like growth factor binding protein‐4 (IGFBP‐4) under normal and pathological conditions

J. van Doorn, S. van Buul-Offers, A. J. F. H. Cornelissen, 2001, Clinical endocrinology.

Growth hormone expression in murine bone marrow cells is independent of the pituitary transcription factor Pit-1.

E. Hooghe-Peters, R. Kooijman, S. van Buul-Offers, 1997, Endocrinology.

Histamine-stimulated expression of insulin-like growth factors in human glioma cells.

P. Roholl, J. Sussenbach, L. V. D. van der Ven, 1997, British Journal of Cancer.

Serum somatomedin activity and cartilage metabolism in acutely fasted, chronically malnourished, and refed rats.

J. van den Brande, D. Price, C. Hoogerbrugge, 1979, Endocrinology.

Dexamethasone-induced growth inhibition of porcine growth plate chondrocytes is accompanied by changes in levels of IGF axis components.

S. van Buul-Offers, J. Koedam, J. Koster, 2002, The Journal of endocrinology.

Primary sequences of insulin-like growth factors 1 and 2 isolated from porcine plasma.

S. Bayne, J. van den Brande, C. Hoogerbrugge, 1991, Journal of chromatography.

Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; a pilot study.

J. Bijlsma, S. van Buul-Offers, H. C. van Paassen, 1984, Acta endocrinologica.

Effects of Selective Nitric Oxide Synthase Inhibition on IGF-1, Caspases and Cytokines in a Newborn Piglet Model of Perinatal Hypoxia-Ischaemia

Changlian Zhu, K. Blomgren, F. Groenendaal, 2002, Developmental Neuroscience.

Thyroxine and triiodothyronine levels in Snell mice.

S. van Buul-Offers, W. Hackeng, W. Schopman, 1983, Acta endocrinologica.

The influence of growth hormone, somatomedins, prolactin and thyroxine on the morphology of the proximal tibial epiphysis and growth plate of Snell dwarf mice.

S. van Buul-Offers, T. Smeets, 1983, Growth.

Clastogenic effects of biosynthetic human growth hormone in Snell dwarf mice and CHO cells in vitro.

P. V. van Buul, S. van Buul-Offers, 1984, Mutation research.

Effects of hormone treatment on chromosomal radiosensitivity of somatic and germ cells of Snell's dwarf mice.

P. V. van Buul, S. van Buul-Offers, 1988, Mutation research.

Effect of hormone treatment on spontaneous and radiation-induced chromosomal breakage in normal and dwarf mice.

P. V. van Buul, S. van Buul-Offers, 1982, Mutation research.

Neuroprotection by Selective Nitric Oxide Synthase Inhibition at 24 Hours After Perinatal Hypoxia-Ischemia

Changlian Zhu, K. Blomgren, F. Groenendaal, 2002, Stroke.

Growth and differentiation of pluripotent embryonal carcinoma cells in the Snell dwarf mouse.

E. van Rongen, S. van Buul-Offers, J. Branger, 1984, British Journal of Cancer.

Binding of somatomedin-A and -C, NSILA-S and insulin to human placental cell membranes.

J. van den Brande, S. van Buul-Offers, 1979, Hormone research.

Overexpression of human IGF-II mRNA in the brain of transgenic mice modulates IGFBP-2 gene expression in the medulla oblongata.

C. Reijnders, S. van Buul-Offers, S. Buul-Offers, 2004, The Journal of endocrinology.

IGF and IGF-binding protein expression in the growth plate of normal, dexamethasone-treated and human IGF-II transgenic mice.

Raoul Rooman, M. Gresnigt, S. van Buul-Offers, 2002, The Journal of endocrinology.

Insulin-like growth factor (IGF) II induced changes in expression of IGF binding proteins in lymphoid tissues of hIGF-II transgenic mice.

S. van Buul-Offers, B. I. Hendriks-Stegeman, J. Koster, 1999, Endocrinology.

Co-administration of IGF-binding protein-3 differentially inhibits the IGF-I-induced total body and organ growth of Snell dwarf mice.

J. van den Brande, C. Hoogerbrugge, S. van Buul-Offers, 1995, Progress in growth factor research.

Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability.

Bart van der Burg, B. van der Burg, S. van Buul-Offers, 2003, The Journal of clinical endocrinology and metabolism.

T cell development in insulin-like growth factor-II transgenic mice.

H. Schuurman, B. Zegers, R. Kooijman, 1995, Journal of immunology.

Isolation and partial characterization of IGF-like peptides from Cohn fraction IV of human plasma.

K. Beyreuther, P. Roepstorff, J. van den Brande, 1990, Acta endocrinologica.

Plasma Insulin-Like Growth Factors (IGFs), IGF-Binding Proteins (IGFBPs), Acid-Labile Subunit (ALS) and IGFBP-3 Proteolysis in Individuals with Clinical Characteristics of Sotos Syndrome

J. Wit, M. Karperien, L. de Boer, 2004, Journal of pediatric endocrinology & metabolism : JPEM.

Human insulin-like growth factor (IGF) binding protein-1 inhibits IGF-I-stimulated body growth but stimulates growth of the kidney in snell dwarf mice.

J. W. Neck, J. V. van Neck, S. Drop, 2000, Endocrinology.

Insulin-like growth factor binding proteins-3 and -5 form sodium dodecyl sulfate-stable multimers.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 1997, Biochemical and biophysical research communications.

The growth of different organs of normal and dwarfed Snell mice, before and during growth hormone therapy.

J. van den Brande, S. van Buul-Offers, S. V. van Buul-Offers, 1981, Acta endocrinologica.

The role of somatomedins in growth regulation.

S. van Buul-Offers, J. Bijlsma, 1983, The Netherlands journal of medicine.

A novel specific bioassay for the determination of glucocorticoid bioavailability in human serum

B. van der Burg, P. T. van der Saag, C. E. van den Brink, 2003, Clinical endocrinology.

Plasma Levels of Insulin-Like Binding Protein-2 in Prepubertal Short Children and Its Diagnostic Value in the Evaluation of Growth Hormone Deficiency

J. van Doorn, S. van Buul-Offers, B. Rikken, 2001, Hormone Research in Paediatrics.

The role of growth hormone and insulin-like growth factors in the immune system

R. Kooijman, S. van Buul-Offers, S. Buul-Offers, 1998, Cellular and Molecular Life Sciences CMLS.

Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice.

C. Hoogerbrugge, S. van Buul-Offers, J. Koedam, 1998, The Journal of endocrinology.

Biosynthetic human growth hormone: effects on growth of Snell dwarf mice.

J. van den Brande, S. van Buul-Offers, 1985, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

Characterization of growth factor activity produced by fetal mouse osteoblasts.

E. J. V. van Zoelen, S. Duursma, C. Hoogerbrugge, 1990, The Journal of endocrinology.

A morphological study of the development of the tibial proximal epiphysis and growth plate of normal and dwarfed Snell mice.

S. van Buul-Offers, T. Smeets, 1983, Growth.

Insulin-like growth factors-I and -II and their binding proteins during postnatal development of dwarf Snell mice before and during growth hormone and thyroxine therapy.

J. van den Brande, C. Hoogerbrugge, S. van Buul-Offers, 1994, Journal of Endocrinology.

Modulation of insulin-like growth factor (IGF) action by IGF-binding proteins in normal, benign, and malignant smooth muscle tissues.

P. Roholl, J. Sussenbach, L. V. D. van der Ven, 1996, The Journal of clinical endocrinology and metabolism.